| 000 | 02471camuu2200397 a 4500 | |
| 001 | 000045667666 | |
| 005 | 20110926163047 | |
| 008 | 110923s2010 gw a b 001 0 eng d | |
| 010 | ▼a 2009933610 | |
| 020 | ▼a 9783540782803 (alk. paper) | |
| 020 | ▼a 354078280X (alk. paper) | |
| 020 | ▼a 9783540782810 (e-ISBN) | |
| 020 | ▼a 3540782818 (e-ISBN) | |
| 035 | ▼a (KERIS)REF000016168245 | |
| 040 | ▼a NLM ▼c NLM ▼d EQO ▼d FUH ▼d PAU ▼d VRC ▼d BTCTA ▼d OHX ▼d YDXCP ▼d GEBAY ▼d DLC ▼d 211009 | |
| 050 | 0 0 | ▼a RC271.N46 ▼b A53 2010 |
| 050 | 1 4 | ▼a RC261 ▼b .R35 v.180 2010 |
| 082 | 0 0 | ▼a 616.99/4061 ▼2 22 |
| 084 | ▼a 616.994061 ▼2 DDCK | |
| 090 | ▼a 616.994061 ▼b A588 | |
| 245 | 0 0 | ▼a Angiogenesis inhibition / ▼c Rudiger Liersch, Wolfgang E. Berdel, Torsten Kessler (eds.). |
| 260 | ▼a Heidelberg : ▼b Springer, ▼c c2010. | |
| 300 | ▼a xiv, 231 p. : ▼b ill. ; ▼c 24 cm. | |
| 490 | 1 | ▼a Recent results in cancer research, ▼x 0080-0015 ; ▼v 180 |
| 504 | ▼a Includes bibliographical references and index. | |
| 505 | 1 | ▼a Angiopoietins / Yvonne Reiss -- HIF-1 alpha and cancer therapy / Mei Yee Koh, Tally R. Spivak-Kroizman, Garth Powis -- Chemokines / Andreas Hippe, Bernhard Homey, Anja Meuller-Homey -- Angiogenesis inhibition in cancer therapy / Iris Appelmann ... [et al.] -- Vascular integrins : therapeutic and imaging targets of tumor angiogenesis / Curzio Ruegg, Gian Carlo Alghisi -- PDGF and vessel maturation / Carina Hellberg, Arne Ostman, C.-H. Heldin -- Lymphangiogenesis in cancer : current perspectives / Rudiger Liersch ... [et al.] -- Compounds in clinical phase III and beyond / Torsten Kessler ... [et al.] -- Metronomic chemotherapy : principles and lessons learned from applications in the treatment of metastatic prostate cancer / Urban Emmenegger ... [et al.] -- Targeting inflammatory cells to improve anti-VEGF therapies in oncology / Hans-Peter Gerber, Ezogelin Olazoglu, Iqbal S. Gerwal -- Antibody-based vascular tumor targeting / Christoph Schliemann, Dario Neri -- Caveolae and cancer / Kerri A. Massey, Jan E. Schnitzer. |
| 650 | 0 | ▼a Neovascularization inhibitors. |
| 650 | 1 2 | ▼a Neoplasms ▼x drug therapy. |
| 650 | 1 2 | ▼a Neovascularization, Pathologic ▼x drug therapy. |
| 650 | 2 2 | ▼a Angiogenesis Inhibitors. |
| 700 | 1 | ▼a Liersch, Rudiger. |
| 700 | 1 | ▼a Berdel, Wolfgang E. |
| 700 | 1 | ▼a Kessler, Torsten. |
| 830 | 0 | ▼a Recent results in cancer research; ▼v 180. |
| 945 | ▼a KLPA |
Holdings Information
| No. | Location | Call Number | Accession No. | Availability | Due Date | Make a Reservation | Service |
|---|---|---|---|---|---|---|---|
| No. 1 | Location Science & Engineering Library/Sci-Info(Stacks2)/ | Call Number 616.994061 A588 | Accession No. 121213226 | Availability Available | Due Date | Make a Reservation | Service |
Contents information
Table of Contents
Angiopoietins.- HIF-1? and Cancer Therapy.- Chemokines.- Angiogenesis Inhibition in Cancer Therapy.- Vascular Integrins: Therapeutic and Imaging Targets of Tumor Angiogenesis.- PDGF and Vessel Maturation.- Lymphangiogenesis in Cancer: Current Perspectives.- Compounds in Clinical Phase III and Beyond.- Metronomic Chemotherapy: Principles and Lessons Learned from Applications in the Treatment of Metastatic Prostate Cancer.- Targeting Inflammatory Cells to Improve Anti-VEGF Therapies in Oncology.- Antibody-Based Vascular Tumor Targeting.- Caveolae and Cancer.
Information Provided By: :
